Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2024 (1)
  • 2023 (2)
  • 2021 (5)
  • 2020 (4)

Subject

  • Prescription Drugs (4)
  • Diversion Division (3)
  • Pharmaceuticals/Pharmacists/Physicians (3)
  • Drug Trafficking (2)
  • Outreach/Drug Prevention (2)
  • Major Law Enforcement Operation (1)
  • Press Conferences (1)
  • Public and Media Affairs - also see Congressional Affairs (1)

Drug Name

  • Methamphetamine (240)
  • Fentanyl (147)
  • Cocaine (139)
  • Heroin (80)
  • Marijuana (Cannabis) (56)
  • Oxycodone (55)
  • Synthetic Opioids (19)
  • Hydromorphone (7)
  • Ecstasy/MDMA (6)
  • Marijuana Concentrates (3)
  • Benzodiazepines (2)
  • LSD (2)
  • Psilocybin (2)
  • Barbiturates (1)
  • GHB (1)
  • Ketamine (1)
  • Methadone (1)
  • Morphine (1)
  • Peyote & Mescaline (1)
  • Steroids (1)
  • Opioids (12)

Field Division

  • Washington, DC (55)
  • Miami (9)
  • Seattle (8)
  • San Francisco (6)
  • Dallas (5)
  • New England (5)
  • Chicago (4)
  • Houston (4)
  • New York (3)
  • St. Louis (3)
  • New Jersey (2)
  • Detroit (1)
  • Rocky Mountain (1)
  • San Diego (1)
  • Atlanta (7)
  • Sede (5)
Clear All Results
PRESS RELEASE

Court Orders North Carolina Pharmacy to Pay $500,000 Penalty and Enters Injunction to Prevent Filling Illegal Controlled Substance Prescriptions

Diciembre 06, 2024
WASHINGTON – A federal court ordered an Elkin, North Carolina, pharmacy to pay a $500,000 penalty and enjoined the pharmacy and its pharmacists from dispensing controlled substances, including opioids, without taking steps to help ensure the drugs will not be abused or diverted. The consent decree resolves a complaint filed...
Diciembre 06, 2024
PRESS RELEASE

Fourth Circuit Upholds Former Tabor City Doctor’s Conviction for Operating a Pill Mill

Junio 26, 2023
NEW BERN, N.C. – A three-judge panel from the Fourth Circuit Court of Appeals issued a unanimous, published opinion affirming former physician Jong Whan Kim’s conviction and sentence for operating a pill mill in Tabor City. The Fourth Circuit’s decision was the first published opinion by the Court upholding a...
Junio 26, 2023
PRESS RELEASE

Wilmington Doctor to Pay $170,000 to Resolve Allegations of Unlawful Prescribing of Opioids

Junio 23, 2023
WILMINGTON, N.C. – Dr. Mark S.T. Armitage, a physician practicing with Pelican Family Medicine in Wilmington, North Carolina, agreed to pay $170,000 to resolve alleged violations of the Controlled Substances Act. Dr. Armitage, who previously surrendered his Drug Enforcement Administration (DEA) registration to prescribe controlled substances, further agreed not to...
Junio 23, 2023
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

Noviembre 17, 2021
Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
Noviembre 17, 2021
PRESS RELEASE

Pharmacist Found Guilty of Illegally Dispensing and Distributing Controlled Substances

Noviembre 10, 2021
ATLANTA - Thomas Ukoshovbera A. Gbenedio has been convicted by a federal jury of illegally dispensing and distributing controlled substances from his pharmacy. “Removing and ultimately eliminating healthcare providers who unlawfully dispense pharmaceutical products for non-medical reasons is an important part of DEA’s mission,” said Special Agent in Charge of...
Noviembre 10, 2021
PRESS RELEASE

Macon Jury Convicts Armed Career Criminal on Gun, Heroin, Meth Charges

Agosto 12, 2021
MACON, Ga. – A federal jury convicted a Macon resident with a lengthy criminal history of possession with intent to distribute methamphetamine, heroin and Tramadol, as well as illegally possessing a firearm and possessing a gun in furtherance of drug trafficking this afternoon. Kelvin Henry, 56, of Macon, was found...
Agosto 12, 2021
PRESS RELEASE

DEA Finalizes Measures to Expand Medication-Assisted Treatment

Junio 28, 2021
WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially in rural areas where those suffering with opioid use disorder may have limited treatment options. Under the final rule published today, DEA registrants who are authorized to dispense methadone...
Junio 28, 2021
PRESS RELEASE

DEA honors federal prosecutors for exemplary work in drug-related cases

Enero 29, 2021
SAN DIEGO – The Drug Enforcement Administration San Diego Field Division presented awards to several federal prosecutors for their exemplary service and dedication to DEA’s mission in San Diego and the surrounding counties. “It was an honor and a privilege to recognize these Assistant U.S. Attorneys along with U.S. Attorney...
Enero 29, 2021
PRESS RELEASE

DEA announces launch of Project Safeguard

Octubre 20, 2020
WASHINGTON – Drug Enforcement Administration Acting Administrator Timothy J. Shea today announced that the DEA will direct resources to help reduce violent crime in communities throughout the country. Under this initiative, called Project Safeguard, DEA will identify and prioritize ongoing drug trafficking investigations with a nexus to violent crime. “D...
Octubre 20, 2020
PRESS RELEASE

International law enforcement operation targeting opioid traffickers on the Darknet results in over 170 arrests worldwide and the seizure of weapons, drugs and over $6.5 million

Septiembre 22, 2020
WASHINGTON – Today, the Department of Justice, through the Joint Criminal Opioid and Darknet Enforcement team, joined Europol to announce the results of Operation DisrupTor, a coordinated international effort to disrupt opioid trafficking on the Darknet. The operation, which was conducted across the United States and Europe, demonstrates the continued...
Septiembre 22, 2020
Showing 1 - 10 of 12 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster